EMEA-001839-PIP01-15 - paediatric investigation plan
Emicizumab
PIPHuman
Roche Registration Limited
Switzerland
Tel.+41 6 6879411
Fax +41 616881560
E-mail: info.paediatrics@roche.com
P/0196/2016: EMA decision of 15 July 2016 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for emicizumab (EMEA-001839-PIP01-15)